Previous 10 | Next 10 |
home / stock / imlff / imlff news
InMed Pharmaceuticals Inc. (IMLFF) Q4 2019 Earnings Conference Call September 19, 2019 10:00 AM ET Company Participants Bruce Colwill - Chief Financial Officer Eric Adams - President & Chief Executive Officer Alexandra Mancini - Senior Vice President of Clinical & Regulat...
InMed Pharmaceuticals ( OTCQX:IMLFF ): Q4 GAAP EPS of -C$0.02. More news on: InMed Pharmaceuticals Inc., Earnings news and commentary, Tech stocks news, , Read more ...
TSX:IN OTCQX:IMLFF VANCOUVER , Sept. 19, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoi...
The following slide deck was published by InMed Pharmaceuticals Inc. in conjunction with this Read more ...
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019 Canada NewsWire VANCOUVER, Sept. 12, 2019 TSX:IN OTCQX:IMLFF VANCOUVER , Sept. 12, 2019 /CNW/ - InMed Pharmaceuticals Inc. (...
Noteworthy events during the week of September 8 - 14 for healthcare investors. More news on: Alnylam Pharmaceuticals, Inc., Johnson & Johnson, Xeris Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...
Martin Bott steps down from the Board of Directors TSX:IN OTCQX:IMLFF VANCOUVER , Sept. 3, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology...
InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit Canada NewsWire VANCOUVER, Aug. 29, 2019 InMed's Eric Hsu and Michael Woudenberg among Event's Expert Speakers VANCOUVER , Aug. 29, 2019 /CNW/ - InMed Phar...
InMed Pharmaceuticals ( OTCQX:IMLFF ) appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer (CFO), effective August 9, 2019. Jeff Charpentier will be stepping down from the role of finance chief. More news on: InMed Pharmaceuticals Inc., Healthcare stocks news, Read more...
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes Canada NewsWire VANCOUVER, Aug. 2, 2019 TSX:IN OTCQX:IMLFF VANCOUVER , Aug. 2, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Compa...
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
IMLFF Stock Symbol:
OTCMKTS Market:
InMed Announces Closing of US$4.5 Million Private Placement PR Newswire VANCOUVER, BC , Feb. 16 , 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medicat...
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 11, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company develo...
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 5, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing...